Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain

ClinicalTrials.gov ID: NCT05177094

Public ClinicalTrials.gov record NCT05177094. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 9:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain

Study identification

NCT ID
NCT05177094
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
155 participants

Conditions and interventions

Interventions

  • LY3526318 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 25, 2022
Primary completion
Oct 12, 2022
Completion
Oct 12, 2022
Last update posted
Nov 21, 2023

2022

United States locations

U.S. sites
35
U.S. states
14
U.S. cities
31
Facility City State ZIP Site status
Synexus Clinical Research US, Inc. Chandler Arizona 85224
Synexus Clinical Research - Glendale Glendale Arizona 85306
Arizona Research Center Phoenix Arizona 85053
Alliance for Multispecialty Research, LLC Tempe Tempe Arizona 85281
Artemis Institute for Clinical Research Riverside California 92503
Artemis Institute for Clinical Research San Diego California 92103
CMR of Greater New Haven Hamden Connecticut 06517
VIN-Julie Schwartzbard Aventura Florida 33180
Suncoast Research Group Miami Florida 33135
University of Miami Don Suffer Clinical Research Building Miami Florida 33136
New Horizon Research Center Miami Florida 33165
Renstar Medical Research Ocala Florida 34470
Synexus Clinical Research US, Inc - Orlando Orlando Florida 32806
Synexus Clinical Research US, Inc. Pinellas Park Florida 33781
Synexus Clinical Research US, Inc - Orlando The Villages Florida 32162
North Georgia Clinical Research Woodstock Georgia 30189
Rocky Mountain Clinical Research Idaho Falls Idaho 83404
Synexus Clinical Research US, Inc. Chicago Illinois 60602
Northwestern University Chicago Illinois 60611
NorthShore University HealthSystem Skokie Illinois 60077
Boston Clinical Trials Boston Massachusetts 02131
Joslin Diabetes Center Boston Massachusetts 02215
ActivMed Practices and Research Methuen Massachusetts 01844
MedVadis Research Corporation Waltham Massachusetts 02451
Great Lakes Research Group, Inc. Bay City Michigan 48706
StudyMetrix Research City of Saint Peters Missouri 63303
Clinvest Research LLC Springfield Missouri 65807
Synexus - Cincinnati Cincinnati Ohio 45236
META Medical Research Institute Dayton Ohio 45432
Altoona Center For Clinical Research Duncansville Pennsylvania 16635
FutureSearch Trials Austin Texas 78731
Cedar Health Research Dallas Texas 75251
Synexus - US San Antonio Texas 78229
Northwest Clinical Research Center Bellevue Washington 98007
Rainier Clinical Research Center Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05177094, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 21, 2023 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05177094 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →